跳至主要内容
临床试验/EUCTR2014-000570-19-AT
EUCTR2014-000570-19-AT进行中(未招募)1 期

Applikation of FSME-IMMUN® in obese persons

Institute of Specific Prophylaxis and Tropical Medicine0 个研究点目标入组 148 人开始时间: 2014年6月10日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
148

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • willingness to sign written informed consent form
  • completed primary TBE immunization and at least 1 booster vaccination
  • participants of both sexes between 18 and 60 years of age
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 74
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • age < 18 and > 60 years
  • BMI 25-30
  • previous TBE infection
  • pregnancy or breast feeding
  • acute infection on day of inclusion (day 0) or at visit 5 (36 months), body temperature > 37,9°C
  • concomitant medications: systemic cortison therapy, chemotherapy, immunotherapy (allergy) immunsuppressive therapy 4 weeks prior or during the study
  • administration of other vaccines 4 weeks before/after day 0
  • planned surgery within 2 weeks before/after TBE booster
  • any contraindication to administration of FSME-Immun® vaccine according to manufacturer's instructions
  • malignant diseases within 5 years prior to the study
  • autoimmune diseases
  • kidney insufficiency, dialysis
  • drug addiction
  • plasma donor
  • receipt of blood transfusions or immunoglobulins within 3 months prior to study entry / within 3 months prior to visit 5
  • Severe disease with hospitalization or surgery 3 months before or during the study

研究者

发起方
Institute of Specific Prophylaxis and Tropical Medicine

相似试验

Application of a TBE-Vaccine in obese persons | 临床试验